{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:48:43Z","timestamp":1770976123589,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ray Nesbitt Chair endowment"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00109-019-01803-y","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T21:02:25Z","timestamp":1561755745000},"page":"1285-1297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A non-beta-lactam antibiotic inhibitor for enterohemorrhagic Escherichia coli O104:H4"],"prefix":"10.1007","volume":"97","author":[{"given":"Haoqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arul","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rani","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Gejji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Karthikeyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7692-2170","authenticated-orcid":false,"given":"Sandun","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"key":"1803_CR1","doi-asserted-by":"crossref","unstructured":"Sengupta S, Chattopadhyay MK, Grossart HP (2013) The multifaceted roles of antibiotics and antibiotic resistance in nature. Front Microbiol 4","DOI":"10.3389\/fmicb.2013.00047"},{"key":"1803_CR2","doi-asserted-by":"crossref","unstructured":"Donowitz, G.R. and G.L. Mandell, Drug-therapy - beta-lactam antibiotics 1 New England J Med, 1988. 318(7): p. 419\u2013426","DOI":"10.1056\/NEJM198802183180706"},{"key":"1803_CR3","doi-asserted-by":"crossref","unstructured":"Stillerman, M. and S.H. Bernstein, Streptococcal pharyngitis therapy. Am J Dis Child, 1964. 107(1): p. 35-&","DOI":"10.1001\/archpedi.1964.02080060037006"},{"key":"1803_CR4","unstructured":"Holten KB (2000) Appropriate prescribing of oral beta-lactam antibiotics. Am Fam Physician 62(3)"},{"issue":"5\u20136","key":"1803_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00253-003-1274-y","volume":"61","author":"R Elander","year":"2003","unstructured":"Elander R (2003) Industrial production of \u03b2-lactam antibiotics. Appl Microbiol Biotechnol 61(5\u20136):385\u2013392","journal-title":"Appl Microbiol Biotechnol"},{"key":"1803_CR6","doi-asserted-by":"crossref","unstructured":"Rohde, H., et al., Open-source genomic analysis of Shiga-toxin-producing E. coli O104:H4. N Engl J Med, 2011. 365(8): p. 718\u2013724","DOI":"10.1056\/NEJMoa1107643"},{"key":"1803_CR7","doi-asserted-by":"crossref","unstructured":"Grad, Y.H., et al., Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011 (vol 109, pg 3065, 2012). Proc Natl Acad Sci U S A, 2012. 109(14): p. 5547\u20135547","DOI":"10.1073\/pnas.1203955109"},{"issue":"1","key":"1803_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0463.2009.02563.x","volume":"118","author":"KF Kong","year":"2010","unstructured":"Kong KF, Schneper L, Mathee K (2010) Beta-lactam antibiotics: from antibiosis to resistance and bacteriology. Apmis 118(1):1\u201336","journal-title":"Apmis"},{"issue":"7743","key":"1803_CR9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","volume":"566","author":"J Lyu","year":"2019","unstructured":"Lyu J, Wang S, Balius TE, Singh I, Levit A, Moroz YS, O\u2019Meara MJ, Che T, Algaa E, Tolmachova K, Tolmachev AA, Shoichet BK, Roth BL, Irwin JJ (2019) Ultra-large library docking for discovering new chemotypes. Nature 566(7743):224\u2013229","journal-title":"Nature"},{"issue":"6","key":"1803_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.sbi.2007.09.011","volume":"17","author":"I Bahar","year":"2007","unstructured":"Bahar I, Chennubhotla C, Tobi D (2007) Intrinsic dynamics of enzymes in the unbound state and relation to allosteric regulation. Curr Opin Struct Biol 17(6):633\u2013640","journal-title":"Curr Opin Struct Biol"},{"issue":"5","key":"1803_CR11","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1021\/jacs.6b12565","volume":"139","author":"KV Mahasenan","year":"2017","unstructured":"Mahasenan KV, Molina R, Bouley R, Batuecas MT, Fisher JF, Hermoso JA, Chang M, Mobashery S (2017) Conformational dynamics in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus, allosteric communication network and enablement of catalysis. J Am Chem Soc 139(5):2102\u20132110","journal-title":"J Am Chem Soc"},{"key":"1803_CR12","doi-asserted-by":"crossref","unstructured":"Mangoni, M., D. Roccatano, and A. Di Nola, Docking of flexible ligands to flexible receptors in solution by molecular dynamics simulation. Proteins: Struct, Funct, and Bioinf, 1999. 35(2): p. 153\u2013162","DOI":"10.1002\/(SICI)1097-0134(19990501)35:2<153::AID-PROT2>3.0.CO;2-E"},{"issue":"13","key":"1803_CR13","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.drudis.2006.05.012","volume":"11","author":"G Klebe","year":"2006","unstructured":"Klebe G (2006) Virtual ligand screening: strategies, perspectives and limitations. Drug Discov Today 11(13):580\u2013594","journal-title":"Drug Discov Today"},{"issue":"5","key":"1803_CR14","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1021\/cr040426m","volume":"106","author":"SA Adcock","year":"2006","unstructured":"Adcock SA, McCammon JA (2006) Molecular dynamics: survey of methods for simulating the activity of proteins. Chem Rev 106(5):1589\u20131615","journal-title":"Chem Rev"},{"issue":"2","key":"1803_CR15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461","journal-title":"J Comput Chem"},{"issue":"7","key":"1803_CR16","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1021\/ct300117j","volume":"8","author":"A Bakan","year":"2012","unstructured":"Bakan A, Nevins N, Lakdawala AS, Bahar I (2012) Druggability assessment of allosteric proteins by dynamics simulations in the presence of probe molecules. J Chem Theory Comput 8(7):2435\u20132447","journal-title":"J Chem Theory Comput"},{"issue":"W1","key":"1803_CR17","doi-asserted-by":"publisher","first-page":"W442","DOI":"10.1093\/nar\/gkw287","volume":"44","author":"J Sunseri","year":"2016","unstructured":"Sunseri J, Koes DR (2016) Pharmit: interactive exploration of chemical space. Nucleic Acids Res 44(W1):W442\u2013W448","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"1803_CR18","doi-asserted-by":"publisher","first-page":"W409","DOI":"10.1093\/nar\/gks378","volume":"40","author":"DR Koes","year":"2012","unstructured":"Koes DR, Camacho CJ (2012) ZINCPharmer: pharmacophore search of the ZINC database. Nucleic Acids Res 40(W1):W409\u2013W414","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"1803_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048228","volume":"7","author":"SA Ahmed","year":"2012","unstructured":"Ahmed SA, Awosika J, Baldwin C, Bishop-Lilly KA, Biswas B, Broomall S, Chain PSG, Chertkov O, Chokoshvili O, Coyne S, Davenport K, Detter JC, Dorman W, Erkkila TH, Folster JP, Frey KG, George M, Gleasner C, Henry M, Hill KK, Hubbard K, Insalaco J, Johnson S, Kitzmiller A, Krepps M, Lo CC, Luu T, McNew LA, Minogue T, Munk CA, Osborne B, Patel M, Reitenga KG, Rosenzweig CN, Shea A, Shen X, Strockbine N, Tarr C, Teshima H, van Gieson E, Verratti K, Wolcott M, Xie G, Sozhamannan S, Gibbons HS, Threat Characterization Consortium (2012) Genomic comparison of Escherichia coli O104:H4 isolates from 2009 and 2011 reveals plasmid, and prophage heterogeneity, including Shiga toxin encoding phage stx2. PLoS One 7(11):e48228","journal-title":"PLoS One"},{"issue":"2","key":"1803_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","volume":"22","author":"K Arnold","year":"2006","unstructured":"Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22(2):195\u2013201","journal-title":"Bioinformatics"},{"issue":"1","key":"1803_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28(1):235\u2013242","journal-title":"Nucleic Acids Res"},{"issue":"Pt 8","key":"1803_CR22","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1107\/S0907444905014356","volume":"61","author":"B Stec","year":"2005","unstructured":"Stec B, Holtz KM, Wojciechowski CL, Kantrowitz ER (2005) Structure of the wild-type TEM-1 beta-lactamase at 1.55 A and the mutant enzyme Ser70Ala at 2.1 A suggest the mode of noncovalent catalysis for the mutant enzyme. Acta Crystallogr D Biol Crystallogr 61(Pt 8):1072\u20131079","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1803_CR23","doi-asserted-by":"crossref","unstructured":"Cahill ST, Cain R, Wang DY, Lohans CT, Wareham DW, Oswin HP, Mohammed J, Spencer J, Fishwick CWG, McDonough MA, Schofield CJ, Brem J (2017) Cyclic boronates inhibit all classes of beta-lactamases. Antimicrob Agents Chemother 61(4)","DOI":"10.1128\/AAC.02260-16"},{"key":"1803_CR24","doi-asserted-by":"crossref","unstructured":"Lee, W., McDonough M., Kotra L., Li Z.H., Silvaggi N.R., Takeda Y., Kelly J.A., Mobashery S., A 1.2-A snapshot of the final step of bacterial cell wall biosynthesis. Proc Natl Acad Sci U S A, 2001. 98(4): p. 1427\u201331","DOI":"10.1073\/pnas.98.4.1427"},{"key":"1803_CR25","unstructured":"Isgro, J.T., et al.,2012 Analysis. Specific heat, in NAMD tutorial. . p. 50\u201353"},{"key":"1803_CR26","doi-asserted-by":"crossref","unstructured":"Vanommeslaeghe, K., Hatcher E., Acharya C., Kundu S., Zhong S., Shim J., Darian E., Guvench O., Lopes P., Vorobyov I., Mackerell AD Jr, CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem, 2010. 31(4): p. 671\u2013690","DOI":"10.1002\/jcc.21367"},{"issue":"31","key":"1803_CR27","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1002\/jcc.23067","volume":"33","author":"W Yu","year":"2012","unstructured":"Yu W, He X, Vanommeslaeghe K, MacKerell AD Jr (2012) Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations. J Comput Chem 33(31):2451\u20132468","journal-title":"J Comput Chem"},{"key":"1803_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.addr.2016.04.029","volume":"101","author":"CA Lipinski","year":"2016","unstructured":"Lipinski CA (2016) Rule of five in 2015 and beyond: target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions. Adv Drug Deliv Rev 101:34\u201341","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"1803_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1469-0691.2006.01454.x","volume":"12","author":"G Kahlmeter","year":"2006","unstructured":"Kahlmeter G, Brown DFJ, Goldstein FW, MacGowan AP, Mouton JW, Odenholt I, Rodloff A, Soussy CJ, Steinbakk M, Soriano F, Stetsiouk O (2006) European Committee on Antimicrobial Susceptibility Testing (EUCAST) technical notes on antimicrobial susceptibility testing. Clin Microbiol Infect 12(6):501\u2013503","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1803_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nprot.2007.521","volume":"3","author":"I Wiegand","year":"2008","unstructured":"Wiegand I, Hilpert K, Hancock REW (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3(2):163\u2013175","journal-title":"Nat Protoc"},{"issue":"6","key":"1803_CR31","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1021\/acs.jctc.8b00263","volume":"14","author":"F Comitani","year":"2018","unstructured":"Comitani F, Gervasio FL (2018) Exploring cryptic pockets formation in targets of pharmaceutical interest with SWISH. J Chem Theory Comput 14(6):3321\u20133331","journal-title":"J Chem Theory Comput"},{"key":"1803_CR32","doi-asserted-by":"publisher","first-page":"12916","DOI":"10.1038\/s41598-018-31176-0","volume":"8","author":"I Galdadas","year":"2018","unstructured":"Galdadas I, Lovera S, P\u00e9rez-Hern\u00e1ndez G, Barnes MD, Healy J, Afsharikho H, Woodford N, Bonomo RA, Gervasio FL, Haider S (2018) Defining the architecture of KPC-2 carbapenemase: identifying allosteric networks to fight antibiotics resistance. Sci Rep 8:12916","journal-title":"Sci Rep"},{"issue":"19","key":"1803_CR33","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.1021\/ja0259640","volume":"124","author":"G Minasov","year":"2002","unstructured":"Minasov G, Wang X, Shoichet BK (2002) An ultrahigh resolution structure of TEM-1 beta-lactamase suggests a role for Glu166 as the general base in acylation. J Am Chem Soc 124(19):5333\u20135340","journal-title":"J Am Chem Soc"},{"key":"1803_CR34","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1093\/bioinformatics\/bty419","volume":"34","author":"AS Rose","year":"2018","unstructured":"Rose AS, Bradley AR, Valasatava Y, Duarte JM, Prli\u0107 A, Rose PW (2018) NGL Viewer: web-based molecular graphics for large complexes. Bioinformatics 34:3755\u20133758","journal-title":"Bioinformatics"},{"key":"1803_CR35","doi-asserted-by":"crossref","unstructured":"Fonze, E., et al., TEM1 beta-lactamase structure solved by molecular replacement and refined structure of the S235A mutant. Acta Crystallogr D Biol Crystallogr, 1995. 51(Pt 5): p. 682\u201394","DOI":"10.1107\/S0907444994014496"},{"issue":"3","key":"1803_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nsb0396-233","volume":"3","author":"NC Strynadka","year":"1996","unstructured":"Strynadka NC et al (1996) Molecular docking programs successfully predict the binding of a beta-lactamase inhibitory protein to TEM-1 beta-lactamase. Nat Struct Biol 3(3):233\u2013239","journal-title":"Nat Struct Biol"},{"issue":"4","key":"1803_CR37","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1128\/MMBR.67.4.593-656.2003","volume":"67","author":"H Nikaido","year":"2003","unstructured":"Nikaido H (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67(4):593\u2013656","journal-title":"Microbiol Mol Biol Rev"},{"issue":"10","key":"1803_CR38","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1021\/acsinfecdis.8b00108","volume":"4","author":"S Acosta-Gutierrez","year":"2018","unstructured":"Acosta-Gutierrez S et al (2018) Getting drugs into Gram-negative bacteria: rational rules for permeation through general porins. Acs Infect Dis 4(10):1487\u20131498","journal-title":"Acs Infect Dis"},{"key":"1803_CR39","doi-asserted-by":"crossref","unstructured":"Bajaj, H., et al., Bacterial outer membrane porins as electrostatic nanosieves: exploring transport rules of small polar molecules. ACS Nano, 2017. 11(6): p. 5465\u20135473","DOI":"10.1021\/acsnano.6b08613"},{"issue":"6","key":"1803_CR40","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1074\/jbc.M115.690156","volume":"291","author":"H Bajaj","year":"2016","unstructured":"Bajaj H, Scorciapino MA, Moyni\u00e9 L, Page MGP, Naismith JH, Ceccarelli M, Winterhalter M (2016) Molecular basis of filtering carbapenems by porins from beta-lactam-resistant clinical strains of Escherichia coli. J Biol Chem 291(6):2837\u20132847","journal-title":"J Biol Chem"},{"issue":"7654","key":"1803_CR41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nature22308","volume":"545","author":"MF Richter","year":"2017","unstructured":"Richter MF, Drown BS, Riley AP, Garcia A, Shirai T, Svec RL, Hergenrother PJ (2017) Predictive compound accumulation rules yield a broad - spectrum antibiotic. Nature 545(7654):299\u2013304","journal-title":"Nature"},{"issue":"23","key":"1803_CR42","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1021\/jm980343w","volume":"41","author":"GS Weston","year":"1998","unstructured":"Weston GS, Bl\u00e1zquez J, Baquero F, Shoichet BK (1998) Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. J Med Chem 41(23):4577\u20134586","journal-title":"J Med Chem"},{"issue":"4","key":"1803_CR43","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1128\/JCM.02322-06","volume":"45","author":"W Song","year":"2007","unstructured":"Song W, Bae IK, Lee YN, Lee CH, Lee SH, Jeong SH (2007) Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol 45(4):1180\u20131184","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1803_CR44","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1128\/AAC.02641-15","volume":"60","author":"LJ Rojas","year":"2016","unstructured":"Rojas LJ, Taracila MA, Papp-Wallace KM, Bethel CR, Caselli E, Romagnoli C, Winkler ML, Spellberg B, Prati F, Bonomo RA (2016) Boronic acid transition state inhibitors active against KPC and other class A beta-lactamases: structure-activity relationships as a guide to inhibitor design. Antimicrob Agents Chemother 60(3):1751\u20131759","journal-title":"Antimicrob Agents Chemother"},{"issue":"13","key":"1803_CR45","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s40265-014-0276-7","volume":"74","author":"A Markham","year":"2014","unstructured":"Markham A (2014) Tavaborole: first global approval. Drugs 74(13):1555\u20131558","journal-title":"Drugs"},{"key":"1803_CR46","doi-asserted-by":"crossref","unstructured":"Lomovskaya O, Sun D, Rubio-Aparicio D, Nelson K, Tsivkovski R, Griffith DC, Dudley MN (2017) Vaborbactam: spectrum of beta-lactamase inhibition and impact of resistance mechanisms on activity in Enterobacteriaceae. Antimicrob Agents Chemother 61(11)","DOI":"10.1128\/AAC.01443-17"},{"key":"1803_CR47","unstructured":"Taylor, N.P.2017 VenatoRx raises $42M to take drug for breaking bacterial resistance to approval. [cited 2018; Available from: https:\/\/www.fiercebiotech.com\/biotech\/venatorx-raises-42m-to-take-drug-for-breaking-bacterial-resistance-to-approval . Accessed 20 Apr 2019"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01803-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-019-01803-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01803-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T11:25:40Z","timestamp":1721474740000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-019-01803-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1803"],"URL":"https:\/\/doi.org\/10.1007\/s00109-019-01803-y","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,28]]},"assertion":[{"value":"11 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}